心脏骤停后脑损伤的临床异质性与表型分型:一种方案未必适合所有人
心脏骤停后脑损伤(PCABI)源于复苏期间及复苏后的损伤性病理生理过程,但多项高质量随机对照试验均获中性结果。原因可能为多方面的,但患者与疾病特异性异质性日益被认为是临床决策的关键因素。传统上PCABI依据简单病史特征(如心脏骤停地点、初始心律、目击与否)分层,但这些特征不能充分反映PCABI的体内严重程度或个体对临床干预的反应。本文综述PCABI与基础病理生理、选择性解剖易损性和脑电模式相关的临床异质性与表型,提出应转向快速表型分型以评估体内损伤严重程度和模式,用于未来靶向治疗,并讨论干预反应异质性的潜在原因及未来研究方向。
要点
- 多项设计良好的随机对照试验在减轻PCABI方面均获中性结果,患者与疾病特异性异质性被认为是临床决策的关键因素。
- 传统依据心脏骤停地点、初始心律、目击与否等简单病史特征分层PCABI,不能充分反映体内PCABI严重程度或个体对临床干预的反应。
- 脓毒症和急性呼吸窘迫综合征等领域已尝试识别早期表型,反映对疾病机制和治疗反应患者间异质性的认识;PCABI应采取类似方法。
- 本文提出转向PCABI严重程度的快速表型分型,聚焦评估体内损伤严重程度和模式,用于未来靶向治疗。
- PCABI表型与基础病理生理、选择性解剖易损性和脑电模式相关,未来研究应聚焦表型分型并将其纳入临床试验。
适用人群与场景
- 心脏骤停复苏后患者,涵盖复苏期间及复苏后发生损伤性病理生理过程的人群。
研究设计与关键结果
- 综述指出,多项设计良好的随机对照试验在减轻PCABI方面均获中性结果,原因可能为多方面的,患者与疾病特异性异质性日益被认为是临床决策的关键因素。
- 综述指出,传统依据简单病史特征(如心脏骤停地点、初始心律、目击与否)分层PCABI,不能充分反映体内PCABI严重程度或个体对临床干预的反应,因此这一方法日益显得不足。
- 综述描述PCABI的临床异质性与表型与基础病理生理、选择性解剖易损性和脑电模式相关,并提出转向PCABI严重程度的快速表型分型,聚焦评估体内损伤严重程度和模式,用于未来靶向治疗。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者提出应转向PCABI严重程度的快速表型分型,聚焦评估体内损伤严重程度和损伤模式,用于未来靶向治疗。
- 作者认为,未来PCABI研究应聚焦表型分型并将这些考虑纳入临床试验。
- 作者指出,传统依据心脏骤停地点、初始心律、目击与否等简单病史特征分层PCABI不足以反映体内PCABI严重程度或个体对临床干预的反应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Post-cardiac arrest brain injury (PCABI) emanates from the injurious pathophysiologic sequelae that take place during and after resuscitation from cardiac arrest. Regrettably, identification of efficacious management strategies to mitigate PCABI has been disappointing with numerous well-conducted randomized control trials yielding neutral results. The reasons for this observation are likely multifactorial, however, increasingly patient and disease-specific heterogeneity is recognized as a crucial factor in clinical decision-making. Traditionally, PCABI has been stratified based upon simple historical characteristics (e.g. location of cardiac arrest, initial rhythm, witnessed vs. unwitnessed) that inadequately reflect in vivo PCABI severity or responses to clinical interventions within individual patients. It is therefore increasingly clear that this approach to PCABI is insufficient. In other syndromes, such as sepsis or acute respiratory distress syndrome, attempts to identify early "phenotypes" of patients reflect growing recognition of considerable between-patient heterogeneity in the disease mechanisms and response to therapeutic interventions. A similar approach should be taken with PCABI. In this review, we described the clinical heterogeneity and phenotypes of PCABI as related to the underlying pathophysiology, selective anatomical vulnerability and electrographic patterns. The overarching aim of the review is the propose a shift to expeditious phenotyping of PCABI severity that focuses on assessing in vivo severity and patterns of injury that could be used for future targeted therapies. We will also discuss potential causes of heterogeneous clinical responses to interventions and highlight future research areas for PCABI that focus on phenotyping and incorporating these considerations into clinical trials.
参考来源
- Sekhon MS, Taccone FS, Skrifvars MB, et al. Clinical heterogeneity and phenotyping of post cardiac arrest brain injury: one size may not fit all. Intensive Care Med. 2025. PMID: 40668231. doi:10.1007/s00134-025-08012-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。